Status:
COMPLETED
Copeptin in Childhood Epilepsy
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
University Children's Hospital Basel
Conditions:
Epilepsy
Febrile Seizures
Eligibility:
All Genders
Up to 5 years
Brief Summary
In many fields of medicine, except seizure disorders, blood biomarkers have captured an integrated part of diagnostic decision making, including copeptin, the surrogate marker of vasopressin release. ...
Detailed Description
Background: Copeptin is a surrogate marker of the pituitary-secreted nonapeptide arginine-vasopressin (AVP) and has gradually replaced AVP in several clinical studies largely due to its structural an...
Eligibility Criteria
Inclusion
- Inclusion Criteria epilepsy-cohort:
- All kind of seizures leading to presentation
- Age below 6 years
- Inclusion Criteria control-cohort:
- Fever without seizures caused by banal infections
- Age below 6 years
- Exclusion Criteria:
- No blood required for medical reasons
Exclusion
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2017
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT01884766
Start Date
April 1 2013
End Date
March 1 2017
Last Update
September 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Children's Hospital Basel
Basel, Switzerland, 4056